(Total Views: 564)
Posted On: 04/26/2020 10:23:59 PM
Post# of 153938
Re: SouthernGold #30029
“Ly, agree, news is coming on all fronts now, even Cancer coming from U.K.”
Cancer has been, and continues go be, the biggest potential indication for leronlimab as a drug and for CYDY as a company. COVID has slowed enrollment of the mTNBC trial, but I don’t doubt results continue to be positive (imaging and laboratory results). Once COVID restrictions are lifted, I believe the mTNBC and basket trial will enroll quicker. If results in the mTNBC trial continue as they have been, the indication will be worth billions alone.
Cancer has been, and continues go be, the biggest potential indication for leronlimab as a drug and for CYDY as a company. COVID has slowed enrollment of the mTNBC trial, but I don’t doubt results continue to be positive (imaging and laboratory results). Once COVID restrictions are lifted, I believe the mTNBC and basket trial will enroll quicker. If results in the mTNBC trial continue as they have been, the indication will be worth billions alone.
(4)
(0)
